Published in Fertil Steril on February 16, 2012
Bleeding patterns during the menopausal transition in the multi-ethnic Study of Women's Health Across the Nation (SWAN): a prospective cohort study. BJOG (2014) 1.40
Clinical practice guidelines on menopause: An executive summary and recommendations. J Midlife Health (2013) 1.27
Classifying menopause stage by menstrual calendars and annual interviews: need for improved questionnaires. Menopause (2013) 1.10
Lifestyle interventions targeting body weight changes during the menopause transition: a systematic review. J Obes (2014) 0.80
Maximizing the clinical utility of antimüllerian hormone testing in women's health. Curr Opin Obstet Gynecol (2014) 0.79
Assessing the utility of methods for menopausal transition classification in a population-based cohort: the CARDIA Study. Maturitas (2013) 0.79
Fertility preservation options after gonadotoxic chemotherapy. Clin Med Insights Reprod Health (2013) 0.78
Sonographic markers of ovarian morphology, but not hirsutism indices, predict serum total testosterone in women with regular menstrual cycles. Fertil Steril (2016) 0.75
Vaginal pH: A marker for menopause. J Midlife Health (2014) 0.75
The Role of Body Fat and Fat Distribution in Hypertension Risk in Urban Black South African Women. PLoS One (2016) 0.75
Menstrual Cycle Hormone Changes in Women Traversing the Menopause: Study Of Women's Health Across the Nation. J Clin Endocrinol Metab (2017) 0.75
Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58
Variations in pattern of pubertal changes in girls. Arch Dis Child (1969) 23.35
Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009. MMWR Morb Mortal Wkly Rep (2010) 6.72
Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril (2001) 5.36
Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol (2009) 3.63
A prospective population-based study of menopausal symptoms. Obstet Gynecol (2000) 3.27
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update (2009) 3.05
Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric (2001) 2.99
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril (2005) 2.90
Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN). Menopause (2005) 2.48
Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab (2003) 2.47
Ovarian aging: mechanisms and clinical consequences. Endocr Rev (2009) 2.45
Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women's Health Across the Nation. Menopause (2009) 2.33
Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab (2008) 2.27
Obesity and reproductive hormone levels in the transition to menopause. Menopause (2010) 2.10
Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril (2010) 2.03
Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab (2006) 2.01
Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab (2004) 2.00
Body size affects measures of ovarian reserve in late reproductive age women. Menopause (2008) 1.93
Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause (2000) 1.93
Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab (2010) 1.93
Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women. J Clin Endocrinol Metab (2008) 1.82
Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause (2004) 1.82
Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril (2006) 1.75
Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry (2010) 1.73
Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med (2005) 1.72
Evaluation of four proposed bleeding criteria for the onset of late menopausal transition. J Clin Endocrinol Metab (2006) 1.67
Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab (2008) 1.60
Stages of Reproductive Aging Workshop (STRAW). J Womens Health Gend Based Med (2001) 1.60
Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001. Menopause (2010) 1.58
Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging. Climacteric (2007) 1.57
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) (2004) 1.57
Follicle stimulating hormone and its rate of change in defining menopause transition stages. J Clin Endocrinol Metab (2008) 1.55
A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update (2007) 1.53
Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab (1999) 1.52
Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab (2009) 1.49
Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab (2007) 1.44
Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril (2001) 1.44
Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer (2010) 1.39
Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab (2008) 1.39
Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer (2010) 1.38
Sleep quality, estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol (2001) 1.34
Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation. Menopause (2007) 1.34
Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod (2007) 1.33
Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod (2004) 1.32
Is this woman perimenopausal? JAMA (2003) 1.31
Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clin Chem Lab Med (2006) 1.28
The ReSTAGE Collaboration: defining optimal bleeding criteria for onset of early menopausal transition. Fertil Steril (2007) 1.28
Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep (2010) 1.26
Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril (1992) 1.26
Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy. Ann Epidemiol (2008) 1.18
Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause (2008) 1.14
Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause (2001) 1.12
Racial and ethnic disparities in reproductive endocrinology and infertility. Am J Obstet Gynecol (2010) 1.12
Factors that influence entry into stages of the menopausal transition. Menopause (2009) 1.11
A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles. Menopause (2008) 1.10
Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod (2000) 1.10
The relationship between obesity and race on inhibin B during the menopause transition. Menopause (2005) 1.09
Racial differences in sex hormone levels in women approaching the transition to menopause. Fertil Steril (2001) 1.08
Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women. J Clin Endocrinol Metab (2000) 1.07
Neuroendocrine physiology of the early and late menopause. Endocrinol Metab Clin North Am (2004) 1.06
Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab (2011) 1.06
Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab (2003) 1.05
Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab (2004) 1.05
Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors. Fertil Steril (2009) 1.04
Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res (2007) 1.04
Progesterone and ovulation across stages of the transition to menopause. Menopause (2009) 1.01
Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause (2010) 1.00
Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting. Fertil Steril (2003) 0.99
Patterns of occurrence and concordance between subjective and objective hot flashes among Muslim and Hindu women in Sylhet, Bangladesh. Am J Hum Biol (2008) 0.98
The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol (2008) 0.97
Bone loss across the menopausal transition. Ann N Y Acad Sci (2010) 0.97
Total and unopposed estrogen exposure across stages of the transition to menopause. Cancer Epidemiol Biomarkers Prev (2009) 0.96
Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age. J Clin Endocrinol Metab (2008) 0.96
Association of physical activity with reproductive hormones: the Penn Ovarian Aging Study. Cancer Epidemiol Biomarkers Prev (2007) 0.95
Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women. Menopause (2007) 0.94
Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges. Fertil Steril (2006) 0.94
The medical management of menopause: a four-country comparison care in urban areas. Maturitas (2008) 0.91
Controlled clinical trial assessing the effect of laparoscopic uterine arterial occlusion on ovarian reserve. J Minim Invasive Gynecol (2010) 0.88
Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles. Fertil Steril (2003) 0.86
Gynecologic issues in geriatric women. J Womens Health (Larchmt) (2011) 0.86
Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle-aged women. J Womens Health (Larchmt) (2005) 0.85
Anti-Müllerian hormone as a marker of ovarian reserve: an update. Womens Health (Lond Engl) (2008) 0.82
Longitudinal, epidemiologic studies of female reproductive aging. Ann N Y Acad Sci (2010) 0.81
Pilot study of racial differences and longitudinal changes in inhibin B in the late reproductive years. Fertil Steril (2002) 0.81
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA (2003) 10.61
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA (2010) 7.12
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet (2009) 5.22
Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med (2009) 4.80
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med (2004) 4.50
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA (2008) 4.42
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol (2005) 3.85
The FMR1 premutation and reproduction. Fertil Steril (2006) 3.85
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol (2012) 3.56
Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab (2006) 3.46
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest (2007) 3.20
Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med (2008) 3.12
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 2.97
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest (2008) 2.69
Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial. Menopause (2010) 2.50
TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab (2010) 2.50
Symptom experience after discontinuing use of estrogen plus progestin. JAMA (2005) 2.32
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab (2012) 2.25
Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr (2011) 2.21
Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial. Arch Intern Med (2005) 2.17
Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab (2013) 2.11
Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci U S A (2010) 2.10
Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci (2009) 2.01
Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol (2007) 1.97
Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause (2002) 1.92
Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A (2006) 1.87
Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med (2005) 1.85
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial. J Bone Miner Res (2008) 1.79
Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit. Fertil Steril (2005) 1.72
Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation (2003) 1.71
Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms. Menopause (2009) 1.67
Genetic testing of embryos: a critical need for data. Reprod Biomed Online (2005) 1.58
Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N Engl J Med (2013) 1.56
Adverse effects of induced hot flashes on objectively recorded and subjectively reported sleep: results of a gonadotropin-releasing hormone agonist experimental protocol. Menopause (2013) 1.54
Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med (2006) 1.50
Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause (2010) 1.47
A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture. Menopause (2015) 1.45
Endocrine assessment of relative reproductive age in normal eumenorrheic younger and older women across multiple cycles. Am J Obstet Gynecol (2003) 1.44
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women. Menopause (2009) 1.42
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause (2012) 1.35
Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial. Obstet Gynecol (2008) 1.34
Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst (2010) 1.31
Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab (2006) 1.30
Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet (2013) 1.26
Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc Natl Acad Sci U S A (2011) 1.26
Genetic variation in the progesterone receptor gene and ovarian cancer risk. Am J Epidemiol (2005) 1.25
A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res (2013) 1.25
Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab (2004) 1.25
p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.24
A genetic basis for functional hypothalamic amenorrhea. N Engl J Med (2011) 1.24
Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer (2005) 1.23
The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study. J Gerontol A Biol Sci Med Sci (2009) 1.21
Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol Biomarkers Prev (2005) 1.21
Blood and urine markers for ovarian cancer: a comprehensive review. Dis Markers (2004) 1.17
Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry (2011) 1.17
Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab (2011) 1.16
Specifications for trueness and precision of a reference measurement system for serum/plasma 25-hydroxyvitamin D analysis. Clin Chim Acta (2009) 1.16
An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril (2005) 1.15
Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric (2012) 1.14
Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. J Clin Endocrinol Metab (2013) 1.13
Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. J Clin Endocrinol Metab (2004) 1.12
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. Cancer Prev Res (Phila) (2011) 1.10
Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab (2013) 1.09
Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism. Eur J Endocrinol (2006) 1.05
Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab (2003) 1.05